Metastatic or Recurrent (QED QBGJ398-301 Proof)

Description

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial

Location: CPMC (San Francisco)

Please contact clinicalresearch@sutterhealth.org about the QED Cholangiocarcinoma Proof trial

View study details on ClinicalTrials.gov

Principal Investigator

Ari Baron, M.D.

Co-Investigator(s)

Bertrand Tuan, MD

Recruitment Status

Active, Recruiting

Start Date

August 23, 2019

Related Studies

Advance Care Planning Practices in Caring for Vulnerable Elders with Multiple Chronic Conditions

To examine the impact of the palliative care program on the patterns of ACP documentation in EHR of patients with multiple chronic conditions.

Investigator: Ellis C. Dillon, Ph.D.

Breast Cancer Chemoprevention in Primary Care at Geisinger

Identify PCPs’ awareness of breast cancer risk assessment and breast cancer chemoprevention knowledge, and identify perceived barriers and clinic solutions.

Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS

Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up

This study seeks to analyze of DNA and RNA isolated from donor tissues for molecular, biochemical, immunological and/or histopathological analysis.

Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions

Our objective is to examine “coverage, price, and reimbursement” for multigene tests broadly and for cancer-related indications.

Investigator: Su-Ying Liang, Ph.D.

Impact of COVID-19 on Cancer Care Management

Study will enhance understanding of cancer care management due to COVID-19.

Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH

Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts

To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.

Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D., External PI, Principal Investigator

Improving Cancer Care

Project will provide information about referrals to palliative care and way to enhance goals of care discussions for patients diagnosed with stage IV cancer.

Investigators: Harold (Hal) Luft, Ph.D., Ellis C. Dillon, Ph.D., Su-Ying Liang, Ph.D.

Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women

The goal of this project is to document incidence and risk factors for lung cancer by smoking status, among AANHPIs, focusing especially on female never smokers.

Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D., Harold (Hal) Luft, Ph.D.

Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)

Provide insights into preventive services for lung cancer. This research will contribute to the concurrent progress in lung cancer screening with LDCT.

Investigators: Jiang Li, Ph.D., MPH, Dorothy Hung, Ph.D., M.A., MPH

Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care

To examine how EHR data can expand understanding of breast cancer pathways--screening to dx and tx.

We've expanded your view